XenoHelix Wins Seoul Bio Hub-Roche Diagnostics 'Startup Spri…
Diagnostic Technology Accumulated Through KMDF Support Leads to Global Collaboration Opportunities XenoHelix is developing molecular diagnostic technology that screens disease risks u..
2026-10-15
XenoHelix Enters Second Production Round of Ultra-Low-Molecu…
▲ XenoHelix has depleted its initial online launch inventory of the 'miPDRN 50K+ Serum' and has entered its second production round. Bio and dermatological science s..
Six Diagnostic Startups in Roche’s Spotlight: XenoHelix Wins…
XenoHelix won the "2026 Seoul-Roche Diagnostics Startup Sprint Demo Day" jointly hosted by Seoul Bio Hub and Roche Diagnostics Korea on September 10. (From left) Hyun-woo Kim, Head of Se..
Seoul Bio Hub and Roche Diagnostics to Host Startup Sprint D…
Six Promising Diagnostic Startups to Pitch Publicly; Winner to Receive Research Funding and Global Collaboration Opportunities. Sharing the Latest Trends in AI-Powered Precision Diagnostics; Experts ..
Nucleic Acid Platform Company XenoHelix Secures KRW 4.5 Bill…
XenoHelix, a nucleic acid isolation and purification platform technology company, announced on August 28, 2026, that it has secured a total of KRW 4.5 billion in Series B funding. &nb..
XenoHelix Showcases Innovative Technologies, Including Ultra…
XenoHelix (CEO Sung-wook Yang) successfully attracted a large number of visitors with its differentiated skincare materials, Exosome and PDRN, at the 2026 Cosmetic Inside Korea exhibition held at ..
Korean Startups Accelerate Market Entry in Shanghai, China
Incheon Center for Creative Economy and Innovation Supports Global Investment Attraction Through ‘Big Wave Global’ The 7 Selected Companies Consist of Sectors with High Technological ..
2026-10-13
XenoHelix and Dong-A Chammed’s Strategic Distribution Agreem…
XenoHelix announced on November 7, 2025, that it has signed a strategic agreement with Dong-A Chammed to secure domestic distribution channels for its next-generation Metabolic Dysfuncti..
XenoHelix Partners with Onheal for Distribution of Ginseng a…
XenoHelix announced on November 3, 2025, that it has signed a strategic partnership agreement with Onheal to supply and accelerate the sales of its premium formulation, 'ExoHeal Boos..
XenoHelix’s Core microRNA Platform Drives Breakthroughs in P…
XenoHelix announced that it successfully participated in Cosmetic Inside Korea 2025, held from April 22 to 25, 2025, at KINTEX in Ilsan. During the exhibition, the company highli..
XenoHelix Showcases Exosome-Based K-Beauty Innovations at Du…
XenoHelix announced on April 16, 2025, that it successfully hosted an exclusive seminar at Dubai Derma 2025, the largest dermatology and skincare exhibition in the Middle East. The semin..
XenoHelix CEO Sung-Wook Yang Focuses on Blood microRNA Analy…
XenoHelix CEO Sung-Wook Yang Outlines Vision to Launch World’s First miRNA-Based Parkinson’s Diagnostic Product XenoHelix CEO Sung-Wook Yang Outlines Launch of World&rsquo..
